(Q40914838)

24 September 2017

1 reference

title

Interleukin-6, a new target for therapy in multiple myeloma? (English)

1 reference

24 September 2017

3

H M Lokhorst

1 reference

24 September 2017

M H van Oers

1

1 reference

PubMed ID

8507716

24 September 2017

H C van Zaanen

series ordinal

2

1 reference

24 September 2017

1 May 1993

1 reference

24 September 2017

1 reference

24 September 2017

66

1 reference

24 September 2017

219-223

1 reference

24 September 2017

5

1 reference

Interleukin-6 and the acute phase response

24 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01738469

Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.

21 January 2018

1 reference

12 December 2020

Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells

1 reference

12 December 2020

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

12 December 2020

In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma

1 reference

12 December 2020

Interleukin-6 enhances human Ig production, but not as a terminal differentiation factor for B lymphocytes

1 reference

12 December 2020

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

1 reference

12 December 2020

Multiple myeloma treated with high dose intravenous melphalan

1 reference

12 December 2020

Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop

1 reference

12 December 2020

Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1

1 reference

12 December 2020

Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma

1 reference

12 December 2020

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

1 reference

12 December 2020

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

1 reference

12 December 2020

IFN-alpha induces autocrine production of IL-6 in myeloma cell lines

1 reference

12 December 2020

Interleukin-4 induces secretion of CSF for granulocytes and CSF for macrophages by peripheral blood monocytes

1 reference

12 December 2020

Cytokine network in human multiple myeloma

1 reference

12 December 2020

C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system

1 reference

12 December 2020

Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma

1 reference

12 December 2020

Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters

1 reference

12 December 2020

The biology of interleukin-6

1 reference

12 December 2020

Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammapathy

1 reference

12 December 2020

Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity

1 reference

12 December 2020

IgG1 plasmacytosis in interleukin 6 transgenic mice

1 reference

12 December 2020

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

1 reference

12 December 2020

Response patterns of purified myeloma cells to hematopoietic growth factors

1 reference

12 December 2020

Management of refractory myeloma: a review

1 reference

12 December 2020

Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins

1 reference

12 December 2020

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

1 reference

12 December 2020

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

12 December 2020

IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release

1 reference

12 December 2020

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma

1 reference

12 December 2020

The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells

1 reference

12 December 2020

BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells

1 reference

12 December 2020

Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)

1 reference

12 December 2020

'Role of bone marrow stromal cells in the growth of human multiple myeloma

1 reference

12 December 2020

Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.

1 reference

12 December 2020

Mechanisms of bone lesions in multiple myeloma.

1 reference

12 December 2020

Prognostic factors with high-dose melphalan for refractory multiple myeloma.

1 reference

12 December 2020

Expression of a novel 3.5-kb macrophage colony-stimulating factor transcript in human myeloma cells

1 reference

12 December 2020

Recombinant interferon- γ inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro

1 reference

12 December 2020

The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma

1 reference

12 December 2020

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

12 December 2020

Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.

1 reference

12 December 2020

Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo

1 reference

12 December 2020

cDNA cloning of murine interleukin-HP1: homology with human interleukin 6.

1 reference

12 December 2020

Chemotherapy of previously untreated multiple myeloma patients: an analysis of recent treatment results.

1 reference

12 December 2020

Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression

1 reference

12 December 2020

Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants

1 reference

12 December 2020

A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro

1 reference

12 December 2020

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor

1 reference

12 December 2020

Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines

1 reference

12 December 2020

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

1 reference

12 December 2020

Glucocorticosteroid-dependent synergy between interleukin 1 and interleukin 6 for human B lymphocyte differentiation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01738469

1 reference

24 September 2017

1 reference

PubMed ID

8507716